VITROGRO Trademark

Glassware for scientific experiments in laboratories; laboratory glassware; cell culture apparatus and related consumable items, namely, tissue culture flasks and multi-welled cell culture plates; bio-reactors, cell farms, culture bags and blood bags, all for cell culturing for industrial, medical or research purposes; bio-reactors, cell farms, culture bags and blood bags, all for cultivation of adherent and non-adherent cells for industrial, medical or research purposes; cell culture apparatus and related disposable items, namely, tissue culture flasks and multi-welled cell culture plates; cell culture apparatus and related disposable items for use in cultivation of adherent and non-adherent cells for industrial, medical or research purposes, namely, bio-reactors, cell farms, culture bags and blood bags; laboratory equipment, namely, flasks, plates, and petri dishes

Biological preparations, namely, spray-on skin and cultured skin grafts for burn treatment and reconstructive ophthalmic or bladder surgeries, and recombinant therapeutic proteins for medical treatment of burns, hard to heal wounds, surgically created wounds, and incisions; pharmaceutical preparations for treating burns and venous ulcers, wounds in diabetics, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and cosmetic surgeries; veterinary preparations for horses, cattle, pigs, cats and dogs for treating burns and venous ulcers, wounds in diabetics, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and excisional surgeries; chemical preparations for cell culture for medical purposes; chemical reagents for medical use; biochemical reagents for medical use; recombinant proteins for medical use; growth factor preparations, namely, vitronectin, fibronectin, insulin-like growth factor-I, insulin-like growth factor II, insulin-like growth factor binding proteins, epidermal growth factor, fibroblast growth factor and formulations comprising one or more of the foregoing proteins or chimeric protein for use in cell culture autologous treatments, and for the treatment of burn and venous ulcer wounds, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after surgery; tissue culture media used for medical purposes; pharmaceutical preparations for skin care used for treating burns, venous ulcers, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and cosmetic surgeries, and for improving the appearance of wrinkles and skin defects; medical dressings, surgical dressings, wound care components, namely wound and surgical dressings; healing components, namely, vitronectin, fibronectin, insulin-like growth factor-I, insulin-like growth factor II, insulin-like growth factor binding proteins, epidermal growth factor, fibroblast growth factor, formulations comprising of one or more of the foregoing proteins or chimeric proteins for use in treatment of burns, diabetic and venous ulcers, and to improve healing after ophthalmic and cosmetic surgery; surgical implants, namely, arterial grafts; implant coatings to encourage healing and incorporation of an implant into the surrounding tissue bed; implant coatings for use in treatment of arthrosclerosis and the treatment of cancer; drugs for medical purposes for treating burns, venous ulcers, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and cosmetic surgeries, and for use with cells and tissue for transplantation, targeted delivery of drugs and bio-pharmaceuticals and for treatment of cancer; drugs for veterinary purposes for use on horses, cattle, pigs, cats or dogs for treating burns, venous ulcers, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and excisional surgeries, and for use with cells and tissue for transplantation, targeted delivery of drugs and bio-pharmaceuticals and for treatment of cancer; and vaccines

Chemicals for use in science and industry, namely, tissue culture media preparations; biological products for use in science and industry, namely, a 3-dimensional living skin model comprising a de-cellurized de-epidermized dermis prepared from donor skin, used for investigating wound healing, pharmaceutics, toxicology, drug sensitivity, drug penetration and drug delivery, and recombinant therapeutic proteins for medical treatments; biochemical products, namely, vitronectin, fibronectin, insulin-like growth factor-I, insulin-like growth factor II, insulin-like growth factor binding proteins, epidermal growth factor, fibroblast growth factors and formulations consisting of one or more of the foregoing proteins or chimeric protein containing any combination of the foregoing proteins or part thereof for use in science and industry for cell culture and tissue engineering research, and manufacturing of vaccines, proteins and bio-pharmaceuticals; kits containing biochemicals, namely, cell culture kits used for research; biochemicals used for cell culture and tissue engineering research and for use in the clinical manufacture of vaccines, proteins, bio-pharmaceuticals, preparations for wound treatments, cell cultures and wound dressings; reagents and recombinant proteins for scientific and research use; chemical preparations for cell culture for scientific and research use; biochemical reagents for scientific and research use; chemical reagents for scientific and research use

Surgical implants, namely, coated stents, cardiac pacemakers, artificial joints, inter-osseous nails, screws and fixation devices

Scientific services, namely, using a 3-dimensional living skin model for testing irritation and sensitivity of topical pharmaceuticals, cosmetics, and medical devices, in vitro efficacy testing of topical wound healing treatments and medical devices for others; technological services, namely, using a 3-dimensional living skin model for developing and identifying cell culture media formulations suitable for industrial cell culture, research or medical use; laboratory research services in the field of pharmaceutical research such as drug discovery, formulation and delivery